Am J Med Genet B Neuropsychiatr Genet

1. CRINION S, Wyse CA, Donohoe G, Lopez LM, et al
   Mendelian randomization analysis using GWAS and eQTL data to investigate the relationship between chronotype and neuropsychiatric disorders and their molecular basis.
   Am J Med Genet B Neuropsychiatr Genet. 2024;195:e32980.
   

   >> Share

   
   

   
   Br J Psychiatry

2. TREUR JL, Thijssen AB, Smit DJA, Tadros R, et al
   Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: genetic exploration of population samples.
   Br J Psychiatry. 2024 Nov 8:1-9. doi: 10.1192/bjp.2024.
   

   >> Share

   
   
3. HALL J
   Schizophrenia - new treatments soon.
   Br J Psychiatry. 2024 Nov 8:1-2. doi: 10.1192/bjp.2024.
   

   >> Share

   
   

   
   Can J Psychiatry

4. DEVOE DJ, Liu L, Braun A, Cadenhead KS, et al
   Cognitive-Behavioural Social Skills Training: Mediation of Treatment Outcomes in a Randomized Controlled Trial for Youth at Risk of Psychosis: L'entrainement aux competences sociales cognitivo-comportementales : variables mediatrices des resultats the
   Can J Psychiatry. 2024 Nov 11:7067437241295636. doi: 10.1177/07067437241295636.
   

   >> Share

   
   
5. KASTER TS, Babujee A, Sharpe I, Rhee TG, et al
   Clinical Characteristics of Inpatients with Schizophrenia Spectrum Disorder Treated with Electroconvulsive Therapy: A Population-Level Cross-Sectional Study: Titre: Caracteristiques cliniques des patients hospitalises presentant un trouble du spectre
   Can J Psychiatry. 2024 Nov 11:7067437241290181. doi: 10.1177/07067437241290181.
   

   >> Share

   
   
6. FAN L, Zhang Z, Ma X, Liang L, et al
   Brain Age Gap as a Predictor of Early Treatment Response and Functional Outcomes in First-Episode Schizophrenia: A Longitudinal Study: L'ecart d'age cerebral comme predicteur de la reponse en debut de traitement et des resultats fonctionnels dans un p
   Can J Psychiatry. 2024 Nov 10:7067437241293981. doi: 10.1177/07067437241293981.
   

   >> Share

   
   

   
   J Clin Psychiatry

7. JAIN R, Chepke C, Davis LL, McIntyre RS, et al
   Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder.
   J Clin Psychiatry. 2024;85:plunaro2417ah.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

8. O'CONNELL P, Alsaffar M
   The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia: The Role of Pseudoephedrine.
   J Clin Psychopharmacol. 2024 Nov 12. doi: 10.1097/JCP.0000000000001930.
   

   >> Share

   
   

   
   J Psychiatry Neurosci

9. FAN L, Zhang Z, Ma X, Liang L, et al
   Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex.
   J Psychiatry Neurosci. 2024;49:E367-E376.
   

   >> Share

   
   

   
   Mol Psychiatry

10. NISHA AJI K, Lalang N, Ramos-Jimenez C, Rahimian R, et al
    Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis and high-risk state.
    Mol Psychiatry. 2024 Nov 7. doi: 10.1038/s41380-024-02816.
    

    >> Share

    
    

    
    Nature

11. HEFFEL MG, Zhou J, Zhang Y, Lee DS, et al
    Temporally distinct 3D multi-omic dynamics in the developing human brain.
    Nature. 2024;635:481-489.
    

    >> Share

    
    

    
    Pharmacopsychiatry

12. DEN TOOM M, Blanken L, Horn I, Veerman S, et al
    Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial.
    Pharmacopsychiatry. 2024;57:290-295.
    

    >> Share

    
    
13. QU K, He Y, Zhang Z, Cao Y, et al
    Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment.
    Pharmacopsychiatry. 2024;57:283-289.
    

    >> Share

    
    

    
    Psychiatry Res

14. KISIANG'ANI IB, Aden M, Mwangi HR, Akena D, et al
    Exploring psychotic symptoms among substance-naive individuals and recent abstainers without a psychosis diagnosis: A cross-country study across Kenya, Uganda, Ethiopia, and South Africa.
    Psychiatry Res. 2024;342:116253.
    

    >> Share

    
    

    
    Schizophr Res

15. POKORNY VJ, Sponheim SR, Olman CA
    Orientation-dependent contextual modulation of contrast in schizophrenia.
    Schizophr Res. 2024;274:492-500.
    

    >> Share

    
    
16. JIMENEZ AM, Green MF
    Self-disturbance in schizophrenia: Updating the research and bridging the gaps.
    Schizophr Res. 2024;274:489-491.
    

    >> Share

    
    
17. DENIS D, Baran B, Mylonas D, Spitzer C, et al
    Sleep oscillations and their relations with sleep-dependent memory consolidation in early course psychosis and first-degree relatives.
    Schizophr Res. 2024;274:473-485.
    

    >> Share

    
    
18. SUN X, Li M, Qiu Y, Su Q, et al
    Plasma NGAL, not IFN-gamma, predicts early treatment response in drug-naive Chinese Han schizophrenia patients.
    Schizophr Res. 2024;274:457-463.
    

    >> Share

    
    
19. LUCKHOFF HK, Del Re EC, Smit R, Kilian S, et al
    Sex versus gender associations with depressive symptom trajectories over 24 months in first-episode schizophrenia spectrum disorders.
    Schizophr Res. 2024;274:450-456.
    

    >> Share

    
    
20. GEBREEGZIABHERE Y, Habatmu K, Cella M, Alem A, et al
    Validation of the Amharic version of Cognitive Assessment Interview (CAI-A) in people with schizophrenia in Ethiopia.
    Schizophr Res. 2024;274:441-449.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share